Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT06321601
Original registry description
The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.